This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sankaran, S. Articles by Parvin, J. D. Search for Related Content PubMed PubMed Citation Articles by Sankaran, S. Articles by Parvin, J. D.

Identification of Domains of BRCA1 Critical for the Ubiquitin-Dependent Inhibition of Centrosome Function

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Requests for reprints: Jeffrey D. Parvin, Department of Pathology, Brigham and Women's Hospital, 77 Avenue Louis Pasteur, NRB630, Boston, MA 02115. Phone: 617-525-4401; Fax: 617-525-4422; E-mail: JParvin{at}rics.bwh.harvard.edu.

The breast and ovarian cancer specific tumor suppressor BRCA1, bound to BARD1, has multiple functions aimed at maintaining genomic stability in the cell. We have shown earlier that the BRCA1/BARD1 E3 ubiquitin ligase activity regulates centrosome-dependent microtubule nucleation. In this study, we tested which domains of BRCA1 and BARD1 were required to control the centrosome function. In the present study, (a) we confirmed that the ubiquitination activity of BRCA1 regulates centrosome number and function in Hs578T breast cancer cells; (b) we observed that both the amino and carboxyl termini of BRCA1 are required for regulation of centrosome function in vitro; (c) an internal domain (770-1,290) is dispensable for centrosome regulation; (d) BARD1 is required for regulation of centrosome function and protein sequences within the terminal 485 amino acids are necessary for activity; and (e) BARD1 is localized at the centrosome throughout the cell cycle. We conclude that the BRCA1-dependent E3 ubiquitin ligase functions to restrain centrosomes in mammary cells, and loss of BRCA1 in the precancerous breast cell leads to centrosomal hypertrophy, a phenotype commonly observed in incipient breast cancer. (Cancer Res 2006; 66(8): 4100-7)

This article has been cited by other articles:

				M. Shimada, R. Sagae, J. Kobayashi, T. Habu, and K. Komatsu Inactivation of the Nijmegen Breakage Syndrome Gene Leads to Excess Centrosome Duplication via the ATR/BRCA1 Pathway Cancer Res., March 1, 2009; 69(5): 1768 - 1775. [Abstract] [Full Text] [PDF]

				M. Shanmugam and N. Hernandez Mitotic Functions for SNAP45, a Subunit of the Small Nuclear RNA-activating Protein Complex SNAPc J. Biol. Chem., May 23, 2008; 283(21): 14845 - 14856. [Abstract] [Full Text] [PDF]

				S. Sankaran, D. E. Crone, R. E. Palazzo, and J. D. Parvin Aurora-A Kinase Regulates Breast Cancer Associated Gene 1 Inhibition of Centrosome-Dependent Microtubule Nucleation Cancer Res., December 1, 2007; 67(23): 11186 - 11194. [Abstract] [Full Text] [PDF]